Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
C - Inaugural Cochrane Workshop
- Type: Other Sessions
- Track: Other Topics
- Presentations: 16
- Moderators:R. Rami-Porta
- Coordinates: 10/27/2013, 07:30 - 12:00, Bayside 204 A+B, Level 2
-
+
C.00 - Inaugural Cochrane Workshop
07:30 - 07:30 | Author(s): K. Fong
- Abstract
Loading... -
+
C.05 - Collecting Data
09:10 - 09:30 | Author(s): N. Pavlakis
- Abstract
No abstract available for this presentation
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-003 - Exon 19 deletions, smoking history and gender as additional predictive factors for treatment benefit with EGFR Tyrosine Kinase Inhibitors in patients harbouring activating EGFR mutations: A Meta-analysis of 1432 patients in six randomised trials.
09:30 - 09:30 | Author(s): P.N. Ding
- Abstract
Loading... -
+
P1.11-029 - The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
09:30 - 09:30 | Author(s): B.T. Li
- Abstract
Loading...
-
+
MO01 - Lung Cancer Biology - Techniques and Platforms
- Type: Mini Oral Abstract Session
- Track: Biology
- Presentations: 10
- Moderators:S. Lu
- Coordinates: 10/28/2013, 10:30 - 12:00, Bayside 204 A+B, Level 2
-
+
MO01.08 - Identifying Strategies For The Treatment Of Acquired EGFR Tyrosine Kinase Inhibitor Resistance
11:05 - 11:10 | Author(s): C. Hasovits
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO07 - NSCLC - Targeted Therapies II
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 14
- Moderators:T. John
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
-
+
MO07.10 - DISCUSSANT
17:05 - 17:15 | Author(s): N. Pavlakis
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO09 - Mesothelioma I
- Type: Mini Oral Abstract Session
- Track:
- Presentations: 14
- Moderators:K. Suzuki
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside 204 A+B, Level 2
-
+
MO09.07 - Disease and Patient Characteristics related to Survival in a large population-based cohort of patients with Malignant Pleural Mesothelioma (MPM)
16:50 - 16:55 | Author(s): A. Linton
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.05 - Poster Session 2 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 27
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.05-011 - Characterisation of chemo-resistant syngeneic orthotopic rat pre-clinical models of mesothelioma.
09:30 - 09:30 | Author(s): A. Hudson
- Abstract
Loading...
-
+
P2.06 - Poster Session 2 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 50
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.06-015 - Novel plasma proteins associated with prognosis in malignant pleural mesothelioma
09:30 - 09:30 | Author(s): S. Kao
- Abstract
Loading...
-
+
P2.10 - Poster Session 2 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.10-040 - Prognostic significance, accuracy and usefulness of oncologists' estimates of survival time for patients starting first-line chemotherapy for advanced non-small-cell lung cancer (ANSCLC)
09:30 - 09:30 | Author(s): B.E. Kiely
- Abstract
Loading...
-
+
PC02 - EGFR as a Target in Early Stage Disease
- Type: Pro/Con Session
- Track: Medical Oncology
- Presentations: 5
- Moderators:N. Pavlakis
- Coordinates: 10/29/2013, 14:00 - 15:30, Parkside Auditorium, Level 1
-
+
PC02.0 - N/A - Chair Intro
14:00 - 14:05
- Abstract
No abstract available for this presentation
-
+
PC02.1 - Introduction: Detection of EGFR Mutations
14:05 - 14:20 | Author(s): F. Hirsch
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PC02.2 - Pro: Patients with EGFR Mutations Should Receive Adjuvant EGFR TKIs
14:20 - 14:40 | Author(s): K. Nakagawa
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PC02.3 - Con: Patients with EGFR Mutations Should Not Receive Adjuvant EGFR TKIs
14:40 - 15:00 | Author(s): C.K. Liam
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PC02.4 - Adjudication and Discussion
15:00 - 15:25 | Author(s): M. Kris
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.11 - Poster Session 3 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.11-012 - Epidermal growth factor receptor tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung.
09:30 - 09:30 | Author(s): M. Ameratunga
- Abstract
Loading... -
+
P3.11-046 - ROS1 overexpression by immunohistochemistry in non-small cell lung cancer: clinical characteristics, natural history and potential new therapeutic target based on two Australian cases
09:30 - 09:30 | Author(s): B.T. Li
- Abstract
Loading...
